Dr. John Cush RheumNow
6 years 4 months ago
Open label, uncontrolled study shows that background use of azathioprine (2mg/kg) in Pegloticase treated refractory gout patients was partly effective - 6/12 completed, 2 still on Rx, 2 PEG ineffective and 2 side effx #EULAR2020 #Gout Abst#THU0410 https://t.co/APZRPCQUFg https://t.co/Nfsq4QjyA5
Mario Pompermayer, MD pompermarioMD
6 years 4 months ago
Use of HCQ was not associated with development of ❤️Heart Failure in patients with RA. There was no statistically significant association between the cumulative dose of HCQ & HF. A good study from #MayoClinic. #EULAR2020 #eular20 https://t.co/yG03e0TAcV
Janet Pope Janetbirdope
6 years 4 months ago
ILD RA has more hospital admissions. Occurs in 14% of RA. Increased mortality. Serious complication of RA @eular_org @RheumNow @CRASCRRheum @earlyarthritis #EULAR2020 OP0039 https://t.co/2N3tulzq3R
Janet Pope Janetbirdope
6 years 4 months ago
Nice surprise as IL23 Guselkumab works not only in PsA but axial PsA. Another Rx option also presented at @eular_org #EULAR2020 @CRASCRRheum @earlyarthritis https://t.co/dUqqagzbeC
Janet Pope Janetbirdope
6 years 4 months ago
Can machine learning/AI predict who will respond & get remission in RA prior to bDMARD? High dose steroids, older age high ESR long disease duration worse outcomes but not same for each drug. OP0023 @eular_org #EULAR2020 @RheumNow @CRASCRRheum @earlyarthritis https://t.co/oNXDVQbzMC
David Liew drdavidliew
6 years 4 months ago
We're still poor at estimating the chance of remission with bDMARDs for individuals w RA - but maybe AI can help provide them with a personalised prediction of their chances of success? Remission predicted here w 57-73% accuracy.
Korean national data OP0023 #EULAR2020 @RheumNow https://t.co/zNw3j5VZni
David Liew drdavidliew
6 years 4 months ago
Tocilizumab in GCA - three year data from GiACTA on steroid exposure and time to flare:
- steroid-sparing benefit persists in both new-onset and relapsing disease
- in avoiding flares, benefit for weekly dosing in both new-onset and relapsing disease
OP0027 #EULAR2020 @RheumNow https://t.co/tGU6ayglHW
Dr. Rachel Tate uptoTate
6 years 4 months ago
"It's a brave new world!" Dr. Iain McInnes, president of #EULAR2020 discussing how the pandemic has created a "technological miracle" by bringing us all virtually together! @RheumNow
Janet Pope Janetbirdope
6 years 4 months ago
Case control study to see if MTX is assoc with ILD in RA. Hypersensitivity pneumonitis pts were excluded. MTX use assoc with DELAYED onset of ILD so protective. let my RA pts use MTX if ILD or increased ILD risk ex male old +RF OP0036 @RheumNow @eular_org @CRASCRRheum #EULAR2020 https://t.co/NGM4t2OKTP
Patrick Kiely pkiely500
6 years 4 months ago
#EULAR2020 OP0026. RITAZAREM. Rituximab superior to Aza 2mg/kg in maintaining remission in relapsing AAV. Flare rate 13% vs 38%. Note Ritux schedule is 1g every 4 months (x 5 infusions out to month 20).
Janet Pope Janetbirdope
6 years 4 months ago
Can we treat GPA /ANCA vasculitis without steroids? Apparently yes +RCT by P Merkel in #EULAR2020 plenary adding avacopan-blocks C5a. Gutsy move as No steroids in one arm! ?cost effectiveness but a breakthrough @RheumNow @eular_org @CRASCRRheum https://t.co/kp7IZOaHfP
This week's Tuesday Nite Rheumatology featured Dr Jonathan Kay (U Mass) who gave an update on Biosimilars and took questions the subject. The program was moderated by Dr. Jack Cush.
For Jessica, an ICU nurse, 12-hour shifts were usually fast paced, challenging and productive. But the cadence and demands of work abruptly changed mid-March when COVID-19 came.
Amongst her many ICU admissions she took care of Larry, who was instantly interesting and forever memorable. He had contracted the coronavirus less than a week before. He was a 60-ish yr. old man who tried to be humorous, but who was clearly distressed and worried. He
k dao KDAO2011
6 years 4 months ago
Dr. R Landewe highlights #EULAR2020 #COVID19 Guidelines:
1. RMD-patients do NOT have higher risk for complications 2. Rheumatologists SHOULD BE involved in management discussions 3. Potential shortages of sDMARDS and biologics
@rheumnow https://t.co/sjQubD7mJL
Mario Pompermayer, MD pompermarioMD
6 years 4 months ago
Patients with RA-ILD vs RA only: More likely to be older, male, white and RF positive. More likely to have COPD, Rheumatoid nodules, erosions, extraarticular disease,⬆️antiCCP,⬆️ESR & ⬆️DAS28(CRP), DAS28(ESR), CDAI & SDAI scores #EULAR2020 #eular20 https://t.co/OhI9NKpStE
